Accelerate Diagnostics, Inc. (OTC:AXDXQ), which has been struggling with a significant debt burden of $66.58 million and negative EBITDA of -$31.89 million, announced Monday that it has completed the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback